Oral HRS-7535 Improved HbA1c in T2DM on Metformin Tags Hypoglycemia hBA1c GLP-1 agonists Biguanide Read more about Oral HRS-7535 Improved HbA1c in T2DM on Metformin
Metformin Showed No Overall Difference in Parkinsonism Risk Tags Biguanide DPP-4 inhibitors Diabetic Neuropathy Read more about Metformin Showed No Overall Difference in Parkinsonism Risk
GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM Tags GLP-1 agonists MASLD/MASH SGLT-2 Inhibitor Thiazolidinediones Read more about GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM
GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM Tags Biguanide Continuous glucose monitoring (CGM) DPP-4 inhibitors GLP-1 agonists Hypoglycemia Long acting Sulphonylureas hBA1c Read more about GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM
Case of Probable Metformin-Induced Erythema Multiforme in Type 2 Diabetes Mellitus Tags ORAL GTT hBA1c Long acting Biguanide Read more about Case of Probable Metformin-Induced Erythema Multiforme in Type 2 Diabetes Mellitus
Best Drug for GDM? Outcomes Differ Across Classes Tags Sulphonylureas GLP-1 agonists Biguanide SGLT-2 Inhibitor Read more about Best Drug for GDM? Outcomes Differ Across Classes
Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM Tags hBA1c Sulphonylureas DPP-4 inhibitors Biguanide Read more about Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM
Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Preadmission Metformin Linked to Lower Mortality in Sepsis Tags Biguanide Read more about Preadmission Metformin Linked to Lower Mortality in Sepsis